BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6278481)

  • 1. Rapid glucocorticoid inhibition of vasoactive intestinal peptide-induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture.
    Rotsztejn WH; Dussaillant M; Nobou F; Rosselin G
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7584-8. PubMed ID: 6278481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dexamethasone regulation of the prolactin release induced by vasoactive intestinal peptide (VIP)].
    Rotsztejn W; Benoist L; Besson J; Duval J
    C R Seances Acad Sci D; 1980 Mar; 290(12):791-3. PubMed ID: 6769606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin 1 (lipocortin 1) mediates the glucocorticoid inhibition of cyclic adenosine 3',5'-monophosphate-stimulated prolactin secretion.
    Taylor AD; Philip JG; John CD; Cover PO; Morris JF; Flower RJ; Buckingham JC
    Endocrinology; 2000 Jun; 141(6):2209-19. PubMed ID: 10830310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vasoactive intestinal peptide (VIP) on the release of adenohypophyseal hormones from purified cells obtained by unit gravity sedimentation. Inhibition by dexamethasone of vip-induced prolactin release.
    Rotsztejn WH; Benoist L; Besson J; Beraud G; Bluet-Pajot MT; Kordon C; Rosselin G; Duval J
    Neuroendocrinology; 1980 Oct; 31(4):282-6. PubMed ID: 7422069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of delta9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells.
    Rodríguez de Fonseca F; Wenger T; Navarro M; Murphy LL
    Brain Res; 1999 Sep; 841(1-2):114-22. PubMed ID: 10546994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depolarization counteracts glucocorticoid inhibition of adenohypophysical corticotroph cells.
    Lim MC; Shipston MJ; Antoni FA
    Br J Pharmacol; 1998 Aug; 124(8):1735-43. PubMed ID: 9756391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone suppresses the release of prolactin from the rat anterior pituitary gland by lipocortin 1 dependent and independent mechanisms.
    Taylor AD; Cowell AM; Flower RJ; Buckingham JC
    Neuroendocrinology; 1995 Nov; 62(5):530-42. PubMed ID: 8559285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release.
    Gourdji D; Bataille D; Vauclin N; Grouselle D; Rosselin G; Tixier-Vidal A
    FEBS Lett; 1979 Aug; 104(1):165-8. PubMed ID: 89971
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid inhibition by somatostatin of vasoactive intestinal peptide-induced prolactin secretion by rat pituitary cells. Relationship to cyclic AMP accumulation.
    Rostene WH; Dussaillant M; Rosselin G
    FEBS Lett; 1982 Sep; 146(1):213-6. PubMed ID: 6183146
    [No Abstract]   [Full Text] [Related]  

  • 12. A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release.
    Pizzi M; Memo M; Benarese M; Simonazzi E; Missale C; Spano PF
    Neuroendocrinology; 1990 Apr; 51(4):481-6. PubMed ID: 2161088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
    Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
    Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of VIP on prolactinemia in turkey anterior pituitary cells: role of cAMP second messenger in VIP-induced prolactin gene expression.
    Kang SW; Youngren OM; El Halawani ME
    Regul Pept; 2002 Nov; 109(1-3):39-44. PubMed ID: 12409212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone inhibits the release of TSH from the rat anterior pituitary gland in vitro by mechanisms dependent on de novo protein synthesis and lipocortin 1.
    Taylor AD; Flower RJ; Buckingham JC
    J Endocrinol; 1995 Dec; 147(3):533-44. PubMed ID: 8543924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription of the vasoactive intestinal peptide gene in response to glucocorticoids: differential regulation of alternative transcripts is modulated by a labile protein in rat anterior pituitary.
    Chew LJ; Burke ZD; Morgan H; Gozes I; Murphy D; Carter DA
    Mol Cell Endocrinol; 1997 Jun; 130(1-2):83-91. PubMed ID: 9220024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
    Bjøro T; Ostberg BC; Sand O; Gordeladze J; Iversen JG; Torjesen PA; Gautvik KM; Haug E
    Mol Cell Endocrinol; 1987 Feb; 49(2-3):119-28. PubMed ID: 2435588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments.
    Pizzi M; Arrighi V; Galli P; Memo M; Spano PF
    Eur J Endocrinol; 1994 Apr; 130(4):361-5. PubMed ID: 8162165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent effects of glucocorticoid on the gene expression of vasoactive intestinal peptide in the rat cerebral cortex and pituitary.
    Lam KS; Srivastava G; Tam SP
    Neuroendocrinology; 1992 Jul; 56(1):32-7. PubMed ID: 1641071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In GH3 pituitary cells, acetylcholine and vasoactive intestinal peptide antagonistically modulate adenylate cyclase, cyclic AMP content, and prolactin secretion.
    Onali P; Eva C; Olianas MC; Schwartz JP; Costa E
    Mol Pharmacol; 1983 Sep; 24(2):189-94. PubMed ID: 6310360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.